Compounded GLP-1 drops or tablets vs injections: do the oral versions work?

Yes—some oral GLP-1 drugs work, but the best-supported ones are FDA-approved or in late-stage trials, not most compounded “drops” or tablets. In clinical studies, oral semaglutide and orforglipron have produced meaningful weight loss and metabolic improvements, but injectable GLP-1s still tend to be a bit more effective overall in head-to-head and comparative data.[1][2][14]

What the evidence shows:

• Oral semaglutide can produce substantial weight loss. Recent high-dose trials reported about 13.6% average weight loss over roughly 71 weeks, which is close to injectable semaglutide’s roughly 15% in comparable trials, though still slightly lower.[2][13]
• Orforglipron has also shown strong results. In phase 3 obesity data, participants lost about 7.8% to 12.4% of body weight depending on dose over 72 weeks, and other reports from later trials suggest results can approach the low-to-mid teens.[3][11]
• Injectables remain the benchmark. Yale Medicine notes that pills and injections work the same way biologically, but injections have a modest edge in trial results, and a meta-analysis found subcutaneous semaglutide produced greater HbA1c lowering than oral semaglutide.[2][14]

For compounded GLP-1 drops or tablets, the evidence is much weaker:

• Experts quoted in recent coverage warn that compounded or non-approved GLP-1 pills have not been proven in large clinical trials for safety and effectiveness.[4]
• Oral peptide drugs can break down in digestion, so compounded versions may have variable formulations and absorption, which makes real-world performance less predictable.[4]

A practical way to think about it:

If you want the most reliable oral option, look for FDA-approved oral semaglutide or a GLP-1 oral agent that has completed phase 3 trials, rather than compounded products.[2][4][13]